Human trial287 female patients12 monthsCohort study

Combined baseline P1NP and TRAcP5b classification predicts differential bone mineral density response to romosozumab: A retrospective cohort study of 287 postmenopausal women

Figure 1 from Journal of Clinical Densitometry
Open the figure at full size
Figure 1Nakano et al.

Journal of Clinical Densitometry

The paper

Mutsu General Hospital (Shimokita Medical Center)

Journal of Clinical Densitometry · 16 Sep 2026

doi.org/10.1016/j.jocd.2026.101747PubMed 42809930